JP2012522793A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522793A5
JP2012522793A5 JP2012503692A JP2012503692A JP2012522793A5 JP 2012522793 A5 JP2012522793 A5 JP 2012522793A5 JP 2012503692 A JP2012503692 A JP 2012503692A JP 2012503692 A JP2012503692 A JP 2012503692A JP 2012522793 A5 JP2012522793 A5 JP 2012522793A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
optionally substituted
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012503692A
Other languages
English (en)
Japanese (ja)
Other versions
JP5651681B2 (ja
JP2012522793A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/029575 external-priority patent/WO2010114971A1/en
Publication of JP2012522793A publication Critical patent/JP2012522793A/ja
Publication of JP2012522793A5 publication Critical patent/JP2012522793A5/ja
Application granted granted Critical
Publication of JP5651681B2 publication Critical patent/JP5651681B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012503692A 2009-04-03 2010-04-01 代謝型グルタミン酸受容体5介在障害の治療のための化合物、およびその使用方法 Expired - Fee Related JP5651681B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16666109P 2009-04-03 2009-04-03
US61/166,661 2009-04-03
US25579009P 2009-10-28 2009-10-28
US61/255,790 2009-10-28
PCT/US2010/029575 WO2010114971A1 (en) 2009-04-03 2010-04-01 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2012522793A JP2012522793A (ja) 2012-09-27
JP2012522793A5 true JP2012522793A5 (cg-RX-API-DMAC7.html) 2013-05-16
JP5651681B2 JP5651681B2 (ja) 2015-01-14

Family

ID=42244504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503692A Expired - Fee Related JP5651681B2 (ja) 2009-04-03 2010-04-01 代謝型グルタミン酸受容体5介在障害の治療のための化合物、およびその使用方法

Country Status (5)

Country Link
US (1) US20120029190A1 (cg-RX-API-DMAC7.html)
EP (1) EP2414340A1 (cg-RX-API-DMAC7.html)
JP (1) JP5651681B2 (cg-RX-API-DMAC7.html)
CA (1) CA2756989A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010114971A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010332819B2 (en) 2009-12-18 2014-02-27 Janssen Pharmaceutica Nv Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
EP2513117B1 (en) 2009-12-18 2013-08-28 Janssen Pharmaceutica, N.V. Bicyclic thiazoles as allosteric modulators of mglur5 receptors
USRE48301E1 (en) 2010-07-09 2020-11-10 Abbvie B.V. Fused heterocyclic derivatives as S1P modulators
US9090632B2 (en) 2010-08-31 2015-07-28 Vanderbilt University Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors
US8703946B2 (en) 2010-12-08 2014-04-22 Vanderbilt University Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors
EP2651222A4 (en) * 2010-12-17 2014-04-30 Univ Vanderbilt BICYCLIC TRIAZOL AND PYRAZOLLACTAME AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS
US8975276B2 (en) 2011-06-29 2015-03-10 Bristol-Myers Squibb Company Inhibitors of PDE10
CN103874702B (zh) * 2011-07-15 2015-12-09 杨森制药公司 作为γ分泌酶调节剂的经取代的吲哚衍生物
DK2799431T3 (en) 2011-12-28 2018-03-26 Fujifilm Corp Hitherto unknown nicotinamide derivatives or salts thereof
BR112014031896A2 (pt) * 2012-06-20 2017-06-27 Univ Vanderbilt composto, composição farmacêutica, e, método para o tratamento de um distúrbio
AR091225A1 (es) 2012-06-22 2015-01-21 Du Pont Compuestos heterociclicos funguicidas
JP2016011257A (ja) * 2012-10-23 2016-01-21 大日本住友製薬株式会社 テトラヒドロオキサゾロピリジン誘導体
WO2014096212A1 (en) 2012-12-20 2014-06-26 Janssen Pharmaceutica Nv NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
KR102171710B1 (ko) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
GB201321749D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
BR112017014226A2 (pt) * 2014-12-29 2018-03-06 Recordati Ireland Limited derivados de heterociclilalquina e sua utilização como moduladores de receptores mglur5
WO2016171181A1 (ja) * 2015-04-21 2016-10-27 大日本住友製薬株式会社 2位置換縮合ピラゾール誘導体
TWI710560B (zh) 2015-11-03 2020-11-21 美商施萬生物製藥研發Ip有限責任公司 用於治療呼吸疾病之jak激酶抑制劑化合物
JP2020504711A (ja) 2016-12-21 2020-02-13 バイオセリックス, インコーポレイテッド タンパク質を標的とすることにおいて使用するための、チエノピロール誘導体、その組成物、方法、および使用
TWI754019B (zh) 2017-03-09 2022-02-01 美商施萬生物製藥研發 Ip有限責任公司 含有4員雜環醯胺之jak抑制劑
EP3619208B1 (en) 2017-05-01 2023-06-07 Theravance Biopharma R&D IP, LLC Crystalline forms of a jak inhibitor compound
AU2018261588A1 (en) 2017-05-01 2019-10-31 Theravance Biopharma R&D Ip, Llc Methods of treatment using a JAK inhibitor compound
AR111495A1 (es) 2017-05-01 2019-07-17 Theravance Biopharma R&D Ip Llc Compuestos de imidazo-piperidina fusionada como inhibidores de jak
EA202091113A1 (ru) 2017-11-02 2020-08-28 Айкурис Гмбх Унд Ко. Кг Новые высокоактивные аминотиазолзамещенные индол-2-карбоксамиды, активные в отношении вируса гепатита b (hbv)
DK3837258T3 (da) 2018-09-04 2024-07-22 Theravance Biopharma R&D Ip Llc Dimethyl amino azetidine amides as jak inhibitors
BR112021004087A2 (pt) 2018-09-04 2021-05-25 Theravance Biopharma R&D Ip, Llc processo para preparar inibidores de jak e seus intermediários
BR112021004063A2 (pt) 2018-09-04 2021-05-25 Theravance Biopharma R&D Ip, Llc amidas heterocíclicas com 5 a 7 membros como inibidores de jak
EP3853229A1 (en) 2018-10-29 2021-07-28 Theravance Biopharma R&D IP, LLC 2-azabicyclo hexane compound as jak inhibitor
KR20220149585A (ko) 2020-03-02 2022-11-08 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 Jak 억제제 화합물의 결정성 수화물
KR102873922B1 (ko) * 2020-07-03 2025-10-20 우한 크리에이터나 사이언스 앤드 테크놀로지 컴퍼니, 리미티드 헤테로고리 화합물 및 이의 용도
TW202317550A (zh) 2021-06-25 2023-05-01 美商施萬生物製藥研發 Ip有限責任公司 作為jak抑制劑之咪唑吲唑化合物
WO2023107722A1 (en) * 2021-12-10 2023-06-15 Prothena Biosciences Limited Compounds for use in treating neurological disorders
EP4596554A4 (en) * 2022-09-29 2025-12-10 Suzhou Arkbiopharmaceutical Co Ltd Fused AZA Cyclic Compound, its Preparation Process and its Use in Medicine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620508A1 (de) * 1965-07-23 1969-09-18 Thomae Gmbh Dr K Verfahren zur Herstellung neuer 4,5,6,7-Tetrahydrothiazolo-[5,4-c]-pyridine
US3503990A (en) * 1967-01-31 1970-03-31 Endo Lab 6-aryl-4,5,6,7-tetrahydro-4-oxoindole derivatives
US3621027A (en) * 1968-03-18 1971-11-16 Endo Lab 1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
WO2004101558A1 (en) * 2003-05-13 2004-11-25 F. Hoffmann-La Roche Ag 2-imidazo-benzothiazoles as adenosine receptor ligands
US7585881B2 (en) * 2004-02-18 2009-09-08 Astrazeneca Ab Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
SG149900A1 (en) * 2004-02-18 2009-02-27 Astrazeneca Ab Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
TW200800204A (en) * 2005-08-15 2008-01-01 Astrazeneca Ab Bicyclic piperazines as metabotropic glutatmate receptor antagonists
GB0622202D0 (en) * 2006-11-07 2006-12-20 Addex Pharmaceuticals Sa Novel compounds
EA201001205A1 (ru) * 2008-01-24 2011-04-29 Юсб Фарма, С.А. Соединения, содержащие циклобутоксигруппу

Similar Documents

Publication Publication Date Title
JP2012510437A5 (cg-RX-API-DMAC7.html)
JP6382977B2 (ja) ジヒドロピリミジン誘導体およびその中間体の製造方法
JP2010520265A5 (cg-RX-API-DMAC7.html)
JP6782774B2 (ja) ピリダジノン除草剤を製造するための中間体、およびそれらを製造するための方法
JP2010532340A5 (cg-RX-API-DMAC7.html)
JP2015508092A5 (cg-RX-API-DMAC7.html)
JP2015042636A5 (ja) 有機化合物
NZ590951A (en) Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders
NZ601967A (en) Pde10 inhibitors and related compositions and methods
JP2021522262A5 (cg-RX-API-DMAC7.html)
JP2007511615A5 (cg-RX-API-DMAC7.html)
JP2022540433A5 (cg-RX-API-DMAC7.html)
JP2008524328A5 (cg-RX-API-DMAC7.html)
JP2023503331A5 (cg-RX-API-DMAC7.html)
JP2019537559A5 (cg-RX-API-DMAC7.html)
JP2022540432A5 (cg-RX-API-DMAC7.html)
CN104470913B (zh) 用于制造羟基化的环戊基嘧啶化合物的方法
JP2013536188A5 (cg-RX-API-DMAC7.html)
JP2006507355A5 (cg-RX-API-DMAC7.html)
JP2012502111A5 (cg-RX-API-DMAC7.html)
JP2014503001A5 (cg-RX-API-DMAC7.html)
JP2012530129A5 (cg-RX-API-DMAC7.html)
JP2022540586A5 (cg-RX-API-DMAC7.html)
JP2019527235A5 (cg-RX-API-DMAC7.html)
CN110997645A (zh) 奥扎尼莫德的制备方法